EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Blogs
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
Kexing Biopharm...
Kexing Biopharm Product List-20251023
Article source：
Oct 22,2025
View： 489
LABEL:
< Kexing Biopharm Product Introduction-20251023
Kexing Biopharm EU and US GMP Product List-20251023 >
BACK TO LIST
Related News
Sep 04,2025
Kexing Biopharm Accelerates R&D and Expands Market Reach: Rising into China’s Top 20 Biopharmaceutical Enterprises
READ MORE >>
Jul 13,2023
Chairman of Kexing Biopharm Deng Xueqin Awarded the First Honorary Fellowship of the Chinese University of Hong...
READ MORE >>
Nov 07,2023
Exploring the Advantages of Chinese Biological Products Bulk Factory
READ MORE >>
Jul 13,2023
Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market
READ MORE >>
Oct 14,2025
How Is Biopharmaceutical Industrialization Shaping the Future of Global Healthcare?
READ MORE >>
Nov 04,2024
Harnessing the Power of Recombinant Collagen Repair Mask for Youthful Skin
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Blogs
Video Center
Contact
Contact Us
Join Us
Article source：
Oct 22,2025
View：
489 
BACK TO LIST
